2020 August 11, 2020 Memo Therapeutics AG and Northway Biotechpharma collaborate on the fast-track manufacturing of a SARS-CoV-2-neutralizing antibody for the therapy of COVID-19 August 10, 2020 Pieris and Lilly enter into a clinical trial collaboration to evaluate combination of PRS-343 with ramucirumab and paclitaxel in gastric cancer July 31, 2020 Ascletis Pharma announces approval for marketing all-oral HCV treatment July 31, 2020 IBM Cloud for Financial Services: Knowis joins ecosystem July 08, 2020 Aruba joins EnOcean Alliance June 04, 2020 Memo Therapeutics AG identifies potent SARS-CoV-2-neutralizing antibodies from the blood of recovered COVID-19 patients April 02, 2020 2020 Sobera Capital acquires three French assets from A Plus Finance March 18, 2020 Memo Therapeutics AG has started the discovery of SARS-CoV2-neutralizing antibodies from COVID-19 patients who have recovered from the infection
